3.5 Million For Single-Cell Cancer Research Into Patient Therapies and Resistance

3.5 Million For Single-Cell Cancer Research Into Patient Therapies and Resistance
Staff at the University of Melbourne have knocked a proposed pay cut and changes to voluntary redundancies. Eriksson Luo/Unsplash
|Updated:
Researchers from the University of Melbourne have received a 3.5 million grant (US$2.51 million) from the Australian Cancer Research Council (ACRF) for the foundation’s new program investigating cancer cells singularly for better patient treatment and causes of treatment resistance.

“This important investment from ACRF will enable us to gain a deeper understanding of how cancers develop at a single-cell level,” said Prof. Andrews Roberts, one of the study’s lead researchers said on March 15.

Marina Zhang
Marina Zhang
Author
Marina Zhang is a health writer for The Epoch Times, based in New York. She mainly covers stories on COVID-19 and the healthcare system and has a bachelors in biomedicine from The University of Melbourne. Contact her at [email protected].
Related Topics